Press release
Infectious Disease Molecular Diagnostics Market Trends Support A 4.9% CAGR Outlook Through The Forecast Period
Infectious Disease Molecular Diagnostics Market
Projected Growth and Market Valuation of the Infectious Disease Molecular Diagnostics Market
The infectious disease molecular diagnostics market is anticipated to steadily increase, reaching a valuation of $38.77 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 4.9%. The market's expansion is fueled by factors such as rising adoption of AI-powered diagnostic technologies, growing demand for fast and accurate testing methods, strengthening healthcare infrastructure in emerging markets, an increased focus on personalized medicine, and the rise of home-based molecular diagnostic solutions. Significant trends expected to influence the market during this period include the broader use of point-of-care diagnostics, heightened interest in multiplex testing, integration of molecular diagnostics with electronic health record (EHR) systems, expansion of infectious disease monitoring programs, and more attention to detecting antimicrobial resistance.
Download a free sample of the infectious disease molecular diagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Leading Companies Driving the Infectious Disease Molecular Diagnostics Market
Several key corporations hold prominent positions in this market, including F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton dic*kinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., and Sherlock Biosciences Inc.
In a notable development in May 2024, Bruker Corporation, a US-based scientific instrument and analytical technology firm, acquired ELITechGroup for $0.94 billion. This strategic acquisition is intended to bolster Bruker's expertise in infectious disease diagnostics by incorporating advanced sample-to-answer molecular diagnostic platforms and a comprehensive range of infectious disease assays that complement its existing portfolio. ELITechGroup SAS, headquartered in France, specializes in molecular diagnostics for infectious diseases.
Emerging Innovations and Trends in the Infectious Disease Molecular Diagnostics Market
Industry leaders are increasingly focused on developing cutting-edge diagnostic solutions, including real-time polymerase chain reaction (PCR) kits that enable fast, precise, and high-throughput detection of infectious agents. Real-time PCR kits work by amplifying and detecting the genetic material of pathogens simultaneously, allowing for speedy and reliable identification of infectious diseases.
For example, in February 2023, Thermo Fisher Scientific Inc., a US biotechnology and life sciences company, introduced Applied Biosystems TaqPath PCR kits in India. These kits offer highly sensitive multiplex diagnostic capabilities that cover the entire workflow from RNA extraction to diagnostic report generation, typically completed within four hours. They feature assays targeting multiple pathogen genomic regions, include internal controls to ensure reliability, and utilize automated data interpretation to reduce user error and improve accuracy.
View the full infectious disease molecular diagnostics market report:
https://www.thebusinessresearchcompany.com/report/infectious-disease-molecular-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR
Detailed Segmentation Overview of the Infectious Disease Molecular Diagnostics Market
The market is segmented across several dimensions for a comprehensive understanding:
1) By Product Type: Kits and Reagents, Instruments, Software and Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips and Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, and Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, and Other Applications
4) By End-User: Hospitals and Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic and Research Institutes
Subcategories include:
- Kits and Reagents such as DNA/RNA extraction kits, PCR reagents, isothermal amplification kits, probe-based detection reagents, and pathogen-specific assay kits
- Instruments including real-time PCR systems, isothermal amplification devices, automated sample preparation systems, next-generation sequencing platforms, and microarray analyzers
- Software and Services covering data analysis and interpretation software, laboratory information management systems, cloud-based infectious disease diagnostic platforms, instrument integration and workflow management tools, and bioinformatics services
This detailed segmentation provides a clear view of the various components contributing to the growth and development of the infectious disease molecular diagnostics market.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Molecular Diagnostics Market Trends Support A 4.9% CAGR Outlook Through The Forecast Period here
News-ID: 4571427 • Views: …
More Releases from The Business Research Company
Intracranial Stents Market Demonstrates Long-Term Growth Potential At 15.6% CAGR
The intracranial stents market is positioned for significant expansion over the coming years, driven by advances in neurovascular treatment options and growing clinical demand. As medical technology evolves, the sector is set to experience considerable growth, fueled by innovations and increasing focus on stroke and aneurysm care. Let us explore the market size projections, the main players, emerging trends, and the key segments shaping this industry.
Rapid Growth Trajectory of the…
Interventional Tumor Ablation Market Outlook Signals Expansion To $2.66 Billion …
The interventional tumor ablation market is positioned for significant growth in the coming years, driven by technological advancements and evolving cancer treatment approaches. This sector is witnessing an increased focus on precision therapies and minimally invasive techniques, which are reshaping how tumors are treated worldwide. Let's explore the market's size projections, key players, emerging trends, and the main segments that define this industry.
Projected Growth and Market Size of the Interventional…
Interventional Neurology Devices And Equipment Market Report 2026 Market Outlook …
The interventional neurology devices and equipment sector is positioned for substantial expansion over the coming years, driven by key technological advances and increasing clinical demands. As medical providers enhance stroke and neurovascular care, this market is becoming increasingly vital. Let's explore the current market valuation, key players, future trends, and the principal segments shaping the industry's trajectory.
Market Size and Growth Outlook for Interventional Neurology Devices and Equipment
The market…
Internal Neuromodulation Devices Market Insights Highlight Segment Expansion And …
The internal neuromodulation devices market is set to experience significant expansion over the coming years, driven by advances in technology and growing demand for personalized treatment options. As healthcare providers and patients increasingly embrace innovative neuromodulation therapies, this sector is positioned for remarkable growth and transformation. Let's explore the market's size projections, key players, emerging trends, and the main segments shaping its evolution.
Projected Market Size and Growth Rate of Internal…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
